Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology/Urology
Disease Category: Erectile Dysfunction
Trial Information
A study to evaluate the efficacy and safety of an orodispersible (ODT) tablet of vardenafil compared to placebo in men with Erectile Dysfunction (ED).
The purpose of the study is to find out if the study drug orodispersible (ODT) tablet of vardenafil 10 mg will be effective and safe compared to placebo (look-a-like pill with no active medication) for the treatment of erectile dysfunction, also known as ED or impotence.
Compensation Provided
Patient Inclusion/Exclusion Criteria:
-Males 18 years-of-age or older.
-Stable, heterosexual relationship for at least 6 months.
-A history of erectile dysfunction (ED) for at least 6 months.
-Any underlying cardiovascular condition, including unstable angina pectoris (chest pain).
-History of myocardial infarction (heart attack), stroke or life-threatening arrhythmia (abnormal heart beat)within 6 months prior to Visit 1.
-History fo sur
Lourdes Campos-Grundvig, RN, MS
Mount Sinai Medical Center
One Gustave L. Levy Place
New York, NY 10029
Phone: (212) 241-3141
Fax: (212) 876-3246
EMail: lourdes.campos-grundvig@mssm.edu
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
